CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Baytacare Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Baytacare Pharmaceutical Co Ltd
No. 3 2nd Road, Gaoxin District
Phone: +86 43264641900p:+86 43264641900 JILIN, JLN  132011  Hong Kong Ticker: 81978197

Business Summary
Baytacare Pharmaceutical Co., Ltd., formerly Northeast Tiger Pharmaceutical Co., Ltd., is principally engaged in the sales of pharmaceutical products. The Company mainly operates through two business segments. The Medicines Business segment is engaged in the development, manufacture and sales of medicines. The Chinese Herbs Business segment is engaged in the planting, cultivation and sales of Chinese herbs. The Company mainly conducts its businesses in Mainland China. The Company is also engaged in the investment holding business through its subsidiaries in the People’s Republic of China (the PRC). Its principal subsidiary includes Antao County Northeast Tiger Xinxing New Products Co., Limited.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201912/31/2018Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board YaoFang 35 6/15/2018 6/15/2018
Chief Financial Officer NanZhu 43 11/28/2016 11/28/2016
Executive Director BingyanCui
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 10 (As of 6/30/2019)
Outstanding Shares: 858,054,000 (As of 6/30/2019)
Stock Exchange: HKG


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, November 12, 2019